Economic Rationality in Decision-Making Regarding Newborn Screening: A Case Study in Quebec

被引:0
作者
Ho, Van Hoa [1 ]
Giguere, Yves [2 ,3 ]
Reinharz, Daniel [1 ]
机构
[1] Laval Univ, Fac Med, Dept Social & Prevent Med, Quebec City, PQ G1V 5C3, Canada
[2] Laval Univ, Fac Med, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1V 5C3, Canada
[3] Univ Laval, CHU Quebec, Res Ctr, Quebec City, PQ G1V 4G2, Canada
关键词
neonatal care; economic evaluation; decision-making; evidence-based medicine; neo-institutional framework; HEALTH TECHNOLOGY-ASSESSMENT; QUALITY;
D O I
10.3390/ijns10020036
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Health systems in high-resource countries recognize the importance of making decisions about the services offered to the population based on scientific evidence. Producing this evidence is especially challenging in areas such as newborn care where the frequency of conditions is rare. However, methodological advances in the field of economic evaluation could change how this evidence is used in decision-making. This study aimed to investigate how decision-makers in the Canadian province of Quebec perceive the value of recent advances in economic evaluations for perinatal studies and how these advances might affect the offer of neonatal interventions in the public health care system. A qualitative study was conducted. A total of 10 policymakers were interviewed. A neo-institutional conceptual framework highlighting three dimensions, structure, power, and interpretive schemes, was used for data collection and analyses. Structural factors, interpretative schemes, and power management between the groups concerned concur to ensure that providing services to newborns is not hindered by the difficulty of producing evidence. They also ensure that the decisions regarding which disease to screen for take into consideration the specificity of neonatology, in particular, the social value given to children not captured by available evidence.
引用
收藏
页数:11
相关论文
共 36 条
  • [11] The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience
    Grosse, Scott D.
    Thompson, John D.
    Ding, Yao
    Glass, Michael
    [J]. MILBANK QUARTERLY, 2016, 94 (02) : 366 - 391
  • [12] Valuing Health Status in the First Year of Life: The Infant Health-Related Quality of Life Instrument
    Jabrayilov, Ruslan
    Vermeulen, Karin M.
    Detzel, Patrick
    Dainelli, Livia
    van Asselt, Antoinette D. I.
    Krabbe, Paul F. M.
    [J]. VALUE IN HEALTH, 2019, 22 (06) : 721 - 727
  • [13] A descriptive system for the Infant health-related Quality of life Instrument (IQI): Measuring health with a mobile app
    Jabrayilov, Ruslan
    van Asselt, Antoinette D. I.
    Vermeulen, Karin M.
    Volger, Sheri
    Detzel, Patrick
    Dainelli, Livia
    Krabbe, Paul F. M.
    [J]. PLOS ONE, 2018, 13 (08):
  • [14] Assessing rare diseases prevalence using literature quantification
    Jason, Shourick
    Maxime, Wack
    Anne-Sophie, Jannot
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [15] A Review of the Quality Indicators of Rigor in Qualitative Research
    Johnson, Jessica L.
    Adkins, Donna
    Chauvin, Sheila
    [J]. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2020, 84 (01) : 138 - 146
  • [16] Data-driven research and healthcare: public trust, data governance and the NHS
    Kerasidou, Angeliki
    Kerasidou, Charalampia
    [J]. BMC MEDICAL ETHICS, 2023, 24 (01)
  • [17] KOELBLE TA, 1995, COMP POLIT, V27, P231, DOI 10.2307/422167
  • [18] Characteristics and quality of pediatric cost-utility analyses
    Kromm, Seija K.
    Bethell, Jennifer
    Kraglund, Ferne
    Edwards, Sarah A.
    Laporte, Audrey
    Coyte, Peter C.
    Ungar, Wendy J.
    [J]. QUALITY OF LIFE RESEARCH, 2012, 21 (08) : 1315 - 1325
  • [19] High-quality health systems in the Sustainable Development Goals era: time for a revolution
    Kruk, Margaret E.
    Gage, Anna D.
    Arsenault, Catherine
    Jordan, Keely
    Leslie, Hannah H.
    Roder-DeWan, Sanam
    Adeyi, Olusoji
    Barker, Pierre
    Daelmans, Bernadette
    Doubova, Svetlana V.
    English, Mike
    Garcia Elorrio, Ezequiel
    Guanais, Frederico
    Gureje, Oye
    Hirschhorn, Lisa R.
    Jiang, Lixin
    Kelley, Edward
    Lemango, Ephrem Tekle
    Liljestrand, Jerker
    Malata, Address
    Marchant, Tanya
    Matsoso, Malebona Precious
    Meara, John G.
    Mohanan, Manoj
    Ndiaye, Youssoupha
    Norheim, Ole F.
    Reddy, K. Srinath
    Rowe, Alexander K.
    Salomon, Joshua A.
    Thapa, Gagan
    Twum-Danso, Nana A. Y.
    Pate, Muhammad
    [J]. LANCET GLOBAL HEALTH, 2018, 6 (11): : E1196 - E1252
  • [20] A Systematic Review of Methods Used by Pediatric Cost-Utility Analyses to Include Family Spillover Effects
    Lamsal, Ramesh
    Yeh, E. Ann
    Pullenayegum, Eleanor
    Ungar, Wendy J.
    [J]. PHARMACOECONOMICS, 2024, 42 (02) : 199 - 217